🇺🇸 FDA
Pipeline program

60 mg PRAX-114 or 40 mg PRAX-114

PRAX-114-221

Phase 2 small_molecule terminated

Quick answer

60 mg PRAX-114 or 40 mg PRAX-114 for Post-traumatic Stress Disorder is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Post-traumatic Stress Disorder
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials